BioRestorative Therapies (BRTX)
Develops autologous cell therapies and cell-secretome cosmetics for spine and metabolic applications.
$2.79
vs last close+0.08 (+3.11%)
Something off on this page? Send us feedback.
Next report
Sep 22, 26
today
EPS estimate
−$2.00
Revenue estimate
$600.0K
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26May '26Sep '26
Reported−$2.60−$7.50−$12.80−$0.30−$0.33−$7.40−$0.24Pending
Estimate−$8.60−$5.40−$6.40−$7.40−$7.20−$7.40−$6.00−$2.00
Surprise+69.8%−38.9%−100.0%+95.9%+95.4%0.0%+96.0%—
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Mar '26May '26Sep '26
Reported$234.0K$500.0K$25.0K$303.0K$11.8K$20.0K$23.2KPending
Estimate$475.0K$483.3K$380.0K$340.0K$460.0K$150.0K$312.5K$600.0K
Surprise−50.7%+3.4%−93.4%−10.9%−97.4%−86.7%−92.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | $0.00 | — | — |
| Sep 2027 | $0.00 | — | — |
| Jun 2027 | $0.00 | — | — |
| Mar 2027 | $0.00 | — | — |
| Dec 2026 | −$1.40 | — | — |
| Nov 2026 | −$1.40 | — | — |
| Sep 2026 | −$2.00 | — | — |
| May 2026 | −$6.00 | −$0.24 | +96.0% |
| Mar 2026 | −$7.40 | −$7.40 | 0.0% |
| Nov 2025 | −$7.20 | −$0.33 | +95.4% |
| Aug 2025 | −$7.40 | −$0.30 | +95.9% |
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $1.0M | — | — | — |
| Sep 2028 | $0.00 | — | — | $975.0K | — | — | — |
| Jun 2028 | $0.00 | — | — | $900.0K | — | — | — |
| Mar 2028 | $0.00 | — | — | $862.5K | — | — | — |
| Dec 2027 | $0.00 | — | — | $844.0K | — | — | — |
| Sep 2027 | $0.00 | — | — | $813.0K | — | — | — |
| Jun 2027 | $0.00 | — | — | $750.0K | — | — | — |
| Mar 2027 | $0.00 | — | — | $719.0K | — | — | — |
| Dec 2026 | −$1.40 | — | — | $675.0K | — | — | — |
| Nov 18, 2026 | −$1.40 | — | — | $650.0K | — | — | — |
| Sep 22, 2026 | −$2.00 | — | — | $600.0K | — | — | — |
| May 13, 2026 | −$6.00 | −$0.24 | +96.0% | $312.5K | $23.2K | −92.6% | −5.8% |
| Mar 26, 2026 | −$7.40 | −$7.40 | 0.0% | $150.0K | $20.0K | −86.7% | −4.5% |
| Nov 12, 2025 | −$7.20 | −$0.33 | +95.4% | $460.0K | $11.8K | −97.4% | −2.1% |
| Aug 12, 2025 | −$7.40 | −$0.30 | +95.9% | $340.0K | $303.0K | −10.9% | +2.0% |
| May 14, 2025 | |||||||
| Apr 4, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| Jun 11, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 21, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 24, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Apr 13, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Nov 13, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 2, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 21, 2017 | |||||||
| Nov 15, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 23, 2015 | |||||||
| Aug 14, 2015 |